Skinbiotherapeutics Share Discussion Threads

[rayrac] 05/12/2018 13:36

Quinn also suggested no upfront milestone payment and low single digit royalties. They know how to sell themselves!!

You’d prefer him to lie slarty, prefer the bullsh*t on Opti thread?

[jammyjim] 05/12/2018 12:58

Thanks for that as I’m driving and haven’t got time for proper looks. Given a bit of time this will bounce back up.

[onedayrodders] 05/12/2018 12:46

jammy .. they were sells .. just filled mid bid / offer

[jammyjim] 05/12/2018 11:57

Two lucky people who bought 40,000 shares at 15.5p Did well out of that. There always blips but it’s just knowing when to buy and to have the confidence to do so.

[bayetya] 05/12/2018 11:50

They certainly know how to reverse a rising share price...

[judijudi] 05/12/2018 10:58

I think this company needs a re-shuffle at the top
imho

[riskybusiness1] 05/12/2018 09:21

IMO they do not have sufficient commercial expertise at this stage. Royalty amounts should differ according to partner. Corporate will bring volume, lower single digits is about the norm. If they do go down pharma route which they are likely to do at some point then there should be milestones. They literally create no excitement from what is a massive opportunity

[onedayrodders] 05/12/2018 09:17

fair comment risky

[riskybusiness1] 05/12/2018 08:48

They also said we'd get some results in December. In terms of cosmetics not covering funds, they likely mean not within the next 12 months as they'll have to sort out distribution after they have proven the science. This takes time. They're not saying cosmetics won't ever produce enough to fund the business. I think they are absolutely hopeless at communicating to shareholders.

[slartybartfaster] 04/12/2018 18:34

Elrico has posted some info from the meeting along with slides. hTTps://lemminginvestors.blogspot.com/2018/12/skinbiotherapuetics-building-ahead-of.html?m=1

[riskybusiness1] 04/12/2018 15:56

Sounds like presentation went well. Hopefully see resulting buys lift the price into the 20s by end of week.

[gostaa] 04/12/2018 15:28

From Twitter today: Just been to a presentation by @SkinBioT, very impressive. Eczema stream is progressing ahead of previous schedule and results of the current trial expected in Q1 19

[riskybusiness1] 03/12/2018 22:33

It's risen like 30% in 3 days looks like it's just taking a breather.

[jammyjim] 03/12/2018 21:26

Very surprised not to have seen more interest today considering one of the long-term posters has said he’s been busy buying between 15.5p and 17.5p. Hopefully we will see a good rise before Christmas. And another good rise on results in January. It probably is people putting money back into OPTi but you do get five times as many shares per £1 here. Buying both is Highly recommended.

[danatkins] 03/12/2018 18:56

Not down much nothing goes in a straight line. If you look at the chart there is a moving average above. This will rerate with good news simples

[gostaa] 03/12/2018 17:44

Was there an investors' presentation today? If so, anyone have the link? I'm also disappointed we were down today but I think investors have sold here to get back into Opti. O'hara said there will be news before Christmas so short term traders have likely piled back in for that reason. I think Opti will go up this week while skin won't move much I'm afraid.

[slartybartfaster] 03/12/2018 14:31

Amazed we are down today.

[someuwin] 03/12/2018 13:06

SkinBioTherapeutics‏ @SkinBioT · 8 minutes ago

Company CEO Cath O'Neill will be giving a lightning talk, a keynote lecture and chairing a session “Cancer and the microbiome” at the 7th Exploring Human Host-Microbiome Interactions in Health and Disease meeting in Hinxton, UK on Dec 5-7, 2018.

[danatkins] 01/12/2018 11:33

Surly anyone planning to attend on Monday found have already researched the company as there is already alot of info out there and Monday's presentation will be a rehash of past presentations

[gostaa] 01/12/2018 01:41

slartybartfaster, if you are correct then we could see a sell off on Tuesday. Please be wrong!